These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 25906930)

  • 21. Intracranial Pulsatility in Relation to Severity and Progression of Cerebral White Matter Hyperintensities.
    Kneihsl M; Hofer E; Enzinger C; Niederkorn K; Horner S; Pinter D; Fandler-Höfler S; Eppinger S; Haidegger M; Schmidt R; Gattringer T
    Stroke; 2020 Nov; 51(11):3302-3309. PubMed ID: 32883195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. White matter hyperintensities and cognitive dysfunction in Alzheimer disease.
    Heo JH; Lee ST; Kon Chu ; Park HJ; Shim JY; Kim M
    J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):207-12. PubMed ID: 19433863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired cerebrovascular reactivity in chronic obstructive pulmonary disease.
    Hlavati M; Buljan K; Tomić S; Horvat M; Butković-Soldo S
    Acta Neurol Belg; 2019 Dec; 119(4):567-575. PubMed ID: 31215005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired Cerebral Autoregulation in Alzheimer's Disease: A Transcranial Doppler Study.
    Zhou G; Zhao X; Lou Z; Zhou S; Shan P; Zheng N; Yu X; Ma L
    J Alzheimers Dis; 2019; 72(2):623-631. PubMed ID: 31594219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered cerebrovascular reactivity velocity in mild cognitive impairment and Alzheimer's disease.
    Richiardi J; Monsch AU; Haas T; Barkhof F; Van de Ville D; Radü EW; Kressig RW; Haller S
    Neurobiol Aging; 2015 Jan; 36(1):33-41. PubMed ID: 25146454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbon dioxide reactivity, pressure autoregulation, and metabolic suppression reactivity after head injury: a transcranial Doppler study.
    Lee JH; Kelly DF; Oertel M; McArthur DL; Glenn TC; Vespa P; Boscardin WJ; Martin NA
    J Neurosurg; 2001 Aug; 95(2):222-32. PubMed ID: 11780891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of middle cerebral artery flow velocity and risk of cognitive decline: A prospective community-based study.
    Xiao Z; Ren X; Zhao Q; Wu W; Liang X; Tang J; Zhang M; Xue Y; Luo J; Ding D; Fu J
    J Clin Neurosci; 2022 Mar; 97():56-61. PubMed ID: 35033782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced Cardiovascular Functions in Patients with Alzheimer's Disease.
    Jin WS; Bu XL; Wang YR; Li L; Li WW; Liu YH; Zhu C; Yao XQ; Chen Y; Gao CY; Zhang T; Zhou HD; Zeng F; Wang YJ
    J Alzheimers Dis; 2017; 58(3):919-925. PubMed ID: 28505975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poststroke Cognitive Decline is Independent of Longitudinal Changes in Cerebral Hemodynamics Parameters.
    Suministrado MSP; Shuang EWY; Xu J; Teoh HL; Chan BP; Venketasubramanian N; Seet RCS; Chen CL; Wong BS; Sharma VK; Dong Y
    J Neuroimaging; 2017 May; 27(3):326-332. PubMed ID: 27623192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of carotid stenting on the hemodynamic parameters and cerebrovascular reactivity of the ipsilateral middle cerebral artery.
    Sfyroeras G; Karkos CD; Liasidis C; Spyridis C; Dimitriadis AS; Kouskouras K; Gerassimidis TS
    J Vasc Surg; 2006 Nov; 44(5):1016-22; discussion 1022. PubMed ID: 17098536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of correction of anemia in end-stage renal disease patients on cerebral circulation and cognitive functions.
    Shaker AM; Mohamed OM; Mohamed MF; El-Khashaba SO
    Saudi J Kidney Dis Transpl; 2018; 29(6):1333-1341. PubMed ID: 30588964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An analysis of changes in cerebral blood flood velocities in depressive pseudo-dementia and Alzheimer disease patients.
    Gucuyener DO; Yenilmez C; Ayranci U; Ozdemir F; Uzuner N; Ozkan S; Kaptanoglu C; Ozdemir G
    Neurologist; 2010 Nov; 16(6):358-63. PubMed ID: 21150383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired cerebrovascular responsiveness and cognitive performance in adults with type 2 diabetes.
    Nealon RS; Howe PR; Jansen L; Garg M; Wong RH
    J Diabetes Complications; 2017 Feb; 31(2):462-467. PubMed ID: 27431891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired cerebral vasoreactivity in type 2 diabetes mellitus.
    Vuletić V; Cengić L; Basić S; Sporis D; Rahelić D; Demarin V
    Coll Antropol; 2011 Mar; 35(1):27-31. PubMed ID: 21661351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of CDP-choline on cognition and cerebral hemodynamics in patients with Alzheimer's disease.
    Caamaño J; Gómez MJ; Franco A; Cacabelos R
    Methods Find Exp Clin Pharmacol; 1994 Apr; 16(3):211-8. PubMed ID: 7913981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impairment of cerebral hemodynamic response to the cold pressor test in patients with Parkinson's disease.
    Tsai SJ; Chen SC; Leu TM; Chen CM; Chou HH; Peng HY; Liao JM; Lin TB
    Parkinsonism Relat Disord; 2009 Feb; 15(2):94-100. PubMed ID: 18440850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral haemodynamics, cognition and brain volumes in patients with type 2 diabetes.
    Brundel M; van den Berg E; Reijmer YD; de Bresser J; Kappelle LJ; Biessels GJ;
    J Diabetes Complications; 2012; 26(3):205-9. PubMed ID: 22520398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired cerebral vasoreactivity to CO2 in Alzheimer's disease using BOLD fMRI.
    Cantin S; Villien M; Moreaud O; Tropres I; Keignart S; Chipon E; Le Bas JF; Warnking J; Krainik A
    Neuroimage; 2011 Sep; 58(2):579-87. PubMed ID: 21745581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT.
    Hirao K; Ohnishi T; Hirata Y; Yamashita F; Mori T; Moriguchi Y; Matsuda H; Nemoto K; Imabayashi E; Yamada M; Iwamoto T; Arima K; Asada T
    Neuroimage; 2005 Dec; 28(4):1014-21. PubMed ID: 16129627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrovascular Effects of Sildenafil in Small Vessel Disease: The OxHARP Trial.
    Webb AJS; Birks JS; Feakins KA; Lawson A; Dawson J; Rothman AMK; Werring DJ; Llwyd O; Stewart CR; Thomas J
    Circ Res; 2024 Jul; 135(2):320-331. PubMed ID: 38832504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.